<ARTICLE> 5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENT.
</LEGEND>
<CIK> 0000316253
<NAME> ENZO BIOCHEM INC.
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-31-1997
<PERIOD-START>                             AUG-01-1996
<PERIOD-END>                               OCT-31-1996
<CASH>                                          23,518
<SECURITIES>                                         0
<RECEIVABLES>                                   21,713
<ALLOWANCES>                                   (6,812)
<INVENTORY>                                      1,736
<CURRENT-ASSETS>                                42,359
<PP&E>                                           8,724
<DEPRECIATION>                                  (5,41)
<TOTAL-ASSETS>                                   6,210
<CURRENT-LIABILITIES>                            2,705
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           231
<OTHER-SE>                                      60,398
<TOTAL-LIABILITY-AND-EQUITY>                    64,210
<SALES>                                          8,005
<TOTAL-REVENUES>                                 8,005
<CGS>                                            3,619
<TOTAL-COSTS>                                    4,725
<OTHER-EXPENSES>                                 3,189
<LOSS-PROVISION>                                 1,536
<INTEREST-EXPENSE>                               (478)
<INCOME-PRETAX>                                    139
<INCOME-TAX>                                        17
<INCOME-CONTINUING>                                122
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       122
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01